NRG-GU002 Archives - NRG Oncology

‘NRG-GU002 Documentation’ of page ‘NRG-GU002’

NRG Oncology Electronic Medical Record Build Pilot Procedures Cover Letter NRG Oncology Electronic Medical Record Build Pilot Procedures NRG Oncology Electronic Medical Record Build Webinar 3/17

‘NRG-GU002: Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel’ of page ‘NRG-GU002’

Principal Investigator Mark Hurwitz, MD Primary Objective To assess the benefit of docetaxel as measured by improvement in freedom from progression (phase II) and subsequently metastasis free survival (phase III) when given in combination with radiation and androgen deprivation in treatment of high risk prostate cancer post-radical prostatectomy Patient Population Pathologically proven diagnosis of adenocarcinoma […]

Content Block Tag: NRG-GU002

‘NRG-GU002 Documentation’ of page ‘NRG-GU002’

‘NRG-GU002: Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel’ of page ‘NRG-GU002’